Biogen Reports First Quarter 2016 Revenues of $2.7 Billion

Go back to Biogen Reports First Quarter 2016 Revenues of $2.7 Billion

Stifel Updates Ests on Biogen (BIIB) Following Q1 Report; Affirms at 'Hold'

April 21, 2016 12:36 PM EDT

Stifel affirms Biogen (Nasdaq: BIIB) at Hold following Q1 results issued earlier Thursday.

Analyst Thomas Shrader offered the following commentary: Biogen presented 1Q16 financial results today,... More

Biogen (BIIB) CEO Scangos Says Co. in Talks for 'Tuck-in' Deals, Later-Stage Assets - Conf. Call

April 21, 2016 8:55 AM EDT

Biogen (NASDAQ: BIIB) CEO Scangos says the company is in talks for 'tuck in' deals and later-stage assets, according to commentary from the company's conference call on Thursday.

... More

Biogen (BIIB) Tops Q1 EPS by 33c

April 21, 2016 7:16 AM EDT

Biogen (NASDAQ: BIIB) reported Q1 EPS of $4.79, $0.33 better than the analyst estimate of $4.46. Revenue for the quarter came in at $2.73 billion versus the consensus estimate of $2.75 billion.

Growth was driven by a 15% increase in worldwide TECFIDERA revenues as well as... More